Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Longitude Venture Partners L.P. Insider Profile
4 Followers
Longitude Venture Partners L.P., Director, Ten Percent Owner at Corcept Therapeutics, holds 14.71M shares in Corcept Therapeutics (Ticker: CORT).
Longitude Venture Partners L.P. Corcept Therapeutics (CORT)Director, Ten Percent Owner
Corcept Therapeutics (CORT)
Director, Ten Percent Owner
Ranked #93,871 out of 98,743 Corporate Insiders
Profitable Transactions
0 out of 4 Profitable Transactions
Average Return
-72.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Longitude Venture Partners L.P.'s holdings
Insider Roles
Director, Ten Percent Owner
Roles that Longitude Venture Partners L.P. holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Apr 01, 2015 - Apr 01, 2016
Return:-16.40%
The most profitable trade made by Longitude Venture Partners L.P.
Longitude Venture Partners L.P.'s Trading History
List of latest transactions for each holding click on a transaction to see Longitude Venture Partners L.P.'s performance on stock
You May Also Like
Longitude Venture Partners L.P. insider profile FAQ
What is the percentage of profitable transactions made by Longitude Venture Partners L.P.?
The percentage of profitable transactions made by Longitude Venture Partners L.P. is 0%.
What is the average return per transaction made by Longitude Venture Partners L.P.?
The average return per transaction made by Longitude Venture Partners L.P. is -72.00%.
What stocks does Longitude Venture Partners L.P. hold?
Longitude Venture Partners L.P. holds: CORT stocks.
What was Longitude Venture Partners L.P.’s latest transaction?
Longitude Venture Partners L.P. latest transaction was an Uninformative Sell of ―.
What was Longitude Venture Partners L.P.'s most profitable transaction?
Longitude Venture Partners L.P.’s most profitable transaction was an Informative Buy of CORT stock on April 1, 2015. The return on the trade was -16.40%.
What is Longitude Venture Partners L.P.'s role in Corcept Therapeutics?
Longitude Venture Partners L.P.'s role in Corcept Therapeutics is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.